Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma
about
Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.Recent Advancement of the Molecular Diagnosis in Pediatric Brain Tumor.
P2860
Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chromosome 1q gain and tenasci ...... ric posterior fossa ependymoma
@en
Chromosome 1q gain and tenasci ...... ic posterior fossa ependymoma.
@nl
type
label
Chromosome 1q gain and tenasci ...... ric posterior fossa ependymoma
@en
Chromosome 1q gain and tenasci ...... ic posterior fossa ependymoma.
@nl
prefLabel
Chromosome 1q gain and tenasci ...... ric posterior fossa ependymoma
@en
Chromosome 1q gain and tenasci ...... ic posterior fossa ependymoma.
@nl
P2093
P2860
P50
P1476
Chromosome 1q gain and tenasci ...... ric posterior fossa ependymoma
@en
P2093
Asuka Araki
Christine Haberler
Harald Heinzl
Inge M Ambros
Irene Slavc
Johannes Gojo
Karin Dieckmann
Thomas Czech
P2860
P2888
P356
10.1186/S40478-016-0349-9
P577
2016-08-22T00:00:00Z